BRCA1 and ovarian cancer: The BRCAPRO model predicts the probability of carrying a BRCA1 or BRCA2 mutation, as determined by the status of breast and ovarian cancer, as well as the ages, of the patient’s first and second-degree relatives, and is guided by the prevalence and penetrance of BRCA1 and BRCA2 mutation in carriers.